September 28, 2016 10:10 AM ET

Capital Markets

Company Overview of Ampersand Capital Partners

Company Overview

Ampersand Capital Partners is a private equity firm specializing in growth equity, expansion, recapitalizations, management buyouts, emerging growth, and corporate divestitures. It invests in lower middle market companies. The firm typically invests in healthcare and industrial sector. Within industrial sector, it focuses on product and process design software, instrumentation for the chemical processing, and environmental industries. Within healthcare sector, the firm focuses on laboratory services, diagnostic testing, regulatory testing, manufacturing support; laboratory products, scientific products, diagnostic products, specialty distribution; contract manufacturing, medical Devices and ...

55 William Street

Suite 240

Wellesley, MA 02481

United States

Founded in 1988





Key Executives for Ampersand Capital Partners

Founder and Managing Partner
Age: 64
Partner, Chief Operating Officer, and Chief Compliance Officer
Managing Partner and Managing General Partner
Age: 51
Director of Tax
General Counsel
Age: 54
Compensation as of Fiscal Year 2016.

Ampersand Capital Partners Key Developments

Ampersand Capital Partners Appoints Frank Witney as an Operating Partner

Ampersand Capital Partners has named Frank Witney, Ph.D, as an operating partner. Dr. Witney is working with Ampersand's investment team to identify and evaluate new investment opportunities as well as assist in the existing portfolio.He has a long and distinguished career in the laboratory products segment of the healthcare industry. Most recently, he served as president and CEO of publicly traded Affymetrix.

Avista Pharma and ATS Labs Seeks Acquisitions

Ampersand Capital Partners said it has appointed Patrick D. Walsh as Chief Executive Officer of Avista Pharma Solutions and ATS Labs, Inc. He will focus on expanding the service offerings of the combined business and evaluating additional acquisition opportunities.

Ampersand Capital Partners Announces Executive Appointments

Ampersand Capital Partners announced that it has appointed Patrick D. Walsh as Chief Executive Officer of Avista Pharma Solutions and Accuratus Labs. In conjunction with Mr. Walsh's appointment, Eric Hess has been named President and Chief Business Officer of the Accuratus Labs business unit. Mr. Walsh has over 30 years of experience building high-achieving, contract development and manufacturing organizations serving the pharmaceutical industry. He will focus on expanding the service offerings of the combined business and evaluating additional acquisition opportunities. Mr. Walsh has led several high growth organizations over the course of his career including as CEO of AAI Pharma Services, CEO of Kadmus Pharmaceuticals, and president and COO of Gensia Sicor. In addition to his executive experience, Mr. Walsh has served on the boards of directors of various companies in the pharmaceutical, biotechnology, and contract service and manufacturing industries.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

August 9, 2016
ETE Medical, Inc.
March 31, 2016
FB2 Services, Inc.
March 24, 2016
Magellan Diagnostics, Inc.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ampersand Capital Partners, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at